Neu Base Therapeutics Inc (NBSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Operating Expenses | 33,318 | 26,566 | 17,069 | 25,510 | 13,904 |
| Operating Income | -33,318 | -26,566 | -17,069 | -25,510 | -13,904 |
| Interest Expense | 24 | 32 | 8 | 129 | 0 |
| Other Income | -434 | 1,189 | -308 | -493 | 667 |
| Pre-tax Income | -33,777 | -25,409 | -17,385 | -26,132 | -13,237 |
| Net Income Continuous | -33,777 | -25,409 | -17,385 | -26,132 | -13,237 |
| Net Income | $-33,777 | $-25,409 | $-17,385 | $-26,132 | $-13,237 |
| EPS Basic Total Ops | -20.80 | -18.60 | -17.80 | -63.20 | -92.00 |
| EPS Basic Continuous Ops | -20.79 | -18.61 | -17.72 | -63.18 | -93.88 |
| EPS Diluted Total Ops | -20.80 | -18.60 | -17.80 | -63.20 | -92.00 |
| EPS Diluted Continuous Ops | -20.79 | -18.61 | -17.72 | -63.18 | -93.88 |
| EBITDA(a) | $-32,056 | $-25,990 | $-16,789 | $-25,266 | $-6,725 |